Vimarsana
Biggest News Aggregation in the World

Page 31 - Celularity Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Celularity Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Celularity Inc Today - Breaking & Trending Today

Maybank, FGV, Pos Malaysia, WTK, Public Bank, Bina Darulaman, Careplus, JF Technology, Media Chinese, Genting - Vimarsana News

Maybank, FGV, Pos Malaysia, WTK, Public Bank, Bina Darulaman, Careplus, JF Technology, Media Chinese, Genting

KUALA LUMPUR (May 11): Based on corporate announcements and news flow today, stocks in focus for tomorrow (May 12) may include the following: Malayan Banking Bhd, FGV Holdings Bhd, Pos Malaysia Bhd, WTK Holdings Bhd, Public Bank Bhd, Bina Darulaman Bhd, Careplus Group Bhd, JF Technology Bhd, Media Chinese International Ltd, and Genting Bhd. Malayan Banking Bhd's (Maybank) 100%-owned subsidiary Maybank Islamic Bhd today announced the buy-back of RM1.5 billion worth of Islamic bonds via private treaty under the latter's Islamic commercial papers and medium term notes programme of up to RM10 bil...

GX Acquisition Corp. Announces Additional Contributions to Trust Account - Vimarsana News

GX Acquisition Corp. Announces Additional Contributions to Trust Account

Share this article Share this article NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GX's amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the "Extension" and such later date, the "Extended Date"). This proposal will be voted on by stockholders at the upcoming special meeting of stockholders on May 14, 2021. The Extension...

GX Acquisition Corp. : Announces Additional Contributions to Trust Account - Vimarsana News

GX Acquisition Corp. : Announces Additional Contributions to Trust Account

Message : Required fields NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to amend GX's amended and restated certificate of incorporation to extend the date by which GX must complete its initial business combination from May 23, 2021 to July 31, 2021 (the "Extension" and such later date, the "Extended Date"). This proposal will be voted on by stockholders at the upcoming special meeting of stockholders on May 14, 2021. The Extension will allow ...

GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination - Vimarsana News

GX Acquisition Corp. Provides Information Regarding Extension of Deadline to Complete Celularity Business Combination

Share this article Share this article NEW YORK, April 16, 2021 /PRNewswire/ -- On April 14, 2021, GX Acquisition Corp. ("GX") (NASDAQ: "GXGX"), provided information regarding a proposal to amend GX's amended and restated certificate of incorporation (the "Charter") to extend the date by which GX has to complete its initial business combination (the "Extension") from May 23, 2021 to July 31, 2021. The Charter currently provides that GX has 24 months from the closing of its initial public offering (until May 23, 2021) to complete an initial business combination, which is customary for a special...

03.03.21 -- Biotech Founders Share Insights On FDA, CMC, And GMP - Vimarsana News

03.03.21 -- Biotech Founders Share Insights On FDA, CMC, And GMP

03.03.21 -- Biotech Founders Share Insights On FDA, CMC, And GMP     As you gear up for your first-in-human studies, your chemistry, manufacturing, and controls (CMC) and medical affairs leaders will come together to play principle — and interdependent — roles in the success of those initiatives. On a recent episode of the  Business of Biotech podcast, Dr. Perez, chief medical officer, and Dr. Ihle, VP of CMC and quality, at Bolt Biotherapeutics, Inc., shared their collective advice for emerging biotech leaders who are new to first-in-human studies.  ...